News

The rationale behind transforming case management in healthcare.

The latest news for pharma industry insiders.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, suggests how to improve visibility and risk management for cold chain shipping.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics.

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

The latest news for pharma industry insiders.

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

Data displayed rapid and sustained B-cell depletion, with 97.2% of study patients with relapsing and primary progressive multiple sclerosis experiencing no relapses.

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

A panel uncovers the value in meeting carbon-neutral goals by 2030.

Data from the Phase III APPLAUSE-IgAN study showed a 38.3% reduction in proteinuria in patients treated with Fabhalta for IgA nephropathy compared to placebo.

Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.

The latest news for pharma industry insiders.

Company also purchased equipment for 12 good manufacturing practice clean rooms.

Capital also expected to assist the advancement of Evergreen's radiopharmaceutical discovery pipeline into clinical trials.

The latest news for pharma industry insiders.

Results of the trial suggest that early intervention for intracerebral hemorrhage using parafascicular surgery were safe.

Phase IIa clinical trial of SPG60 for Fragile X syndrome offers hope for disease with no current FDA-approved treatment options.

The latest news for pharma industry insiders.

A difference-in-differences analysis explores the correlation between direct-acting antiviral prescriptions for hepatitis C virus and the softening of state-level limitations.

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

The latest news for pharma industry insiders.

A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs.

Companies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.

The latest news for pharma industry insiders.

Wattala warehouse is expected to offer both export consolidation and 3PL services for trade routes that link Africa, Asia, and Europe.

The latest news for pharma industry insiders.

If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.